NCT02122913 2026-02-05
A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat Cancer
Bayer
Phase 1 Completed
Bayer
Bristol-Myers Squibb
Bristol-Myers Squibb
Canadian Cancer Trials Group
Bristol-Myers Squibb
PharmaMar
Hoffmann-La Roche